Market Estimates
Valuation Metrics
Financials
Trading Trends
ENTA News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Enanta Pharmaceuticals Inc (ENTA) stock price today?
The current price of ENTA is 13.11 USD — it has decreased -2.46 % in the last trading day.
What is Enanta Pharmaceuticals Inc (ENTA)'s business?
Enanta Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. The Company’s clinical programs are focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including receptor tyrosine kinase (KIT) and STAT6 inhibition. The Company has two clinical-stage product candidates for RSV, which are zelicapavir and EDP-323. Glecaprevir, a protease inhibitor discovered by the Company, is part of one of the treatment regimens for curing chronic hepatitis c virus (HCV) infection and is sold by AbbVie in various countries under the tradenames MAVYRET (U.S.) and MAVIRET (ex-U.S.) (glecaprevir/pibrentasvir). The Company also has development programs in virology for SARS-CoV-2 and Hepatitis B virus.
What is the price predicton of ENTA Stock?
Wall Street analysts forecast ENTA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENTA is 17.00 USD with a low forecast of 9.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Enanta Pharmaceuticals Inc (ENTA)'s revenue for the last quarter?
Enanta Pharmaceuticals Inc revenue for the last quarter amounts to 15.13M USD, increased 3.55 % YoY.
What is Enanta Pharmaceuticals Inc (ENTA)'s earnings per share (EPS) for the last quarter?
Enanta Pharmaceuticals Inc. EPS for the last quarter amounts to -0.87 USD, decreased -36.03 % YoY.
What changes have occurred in the market's expectations for Enanta Pharmaceuticals Inc (ENTA)'s fundamentals?
How many employees does Enanta Pharmaceuticals Inc (ENTA). have?
Enanta Pharmaceuticals Inc (ENTA) has 120 emplpoyees as of January 11 2026.
What is Enanta Pharmaceuticals Inc (ENTA) market cap?
Today ENTA has the market capitalization of 378.39M USD.



![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251226230333_fd631ca9cc459953cfe9cd75ca0ad768.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2Ffe328cf4972df7fbd5f0bd1b6461a35b7e011cc4db88bef00984f99ea23914b6.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F29124b9ce19d2f63cf4d64dbeb6cb21767158e1def9163ce4433cbb520160473.png&w=384&q=75)